Message to ViVitro Labs customers regarding COVID-19 and ViVitro Operations

This is a challenging time for all of us. The health crisis that the world is facing today is unprecedented and is forcing all to reassess the way we live together and do business.  We are all finding ways to work safely and doing everything possible to continue serving our customers around the world quickly and with the highest quality.

ViVitro and ProtomedLabs expertise and resources continue to address testing needs and support R&D programs.

Our ISO 17025 laboratories located in Victoria, Canada and Marseille, France are fully operational. We have put strict measures in place to continue providing laboratory contract services and delivering high quality equipment while ensuring the safety of our clients and employees.

StarFish Medical is maintaining manufacturing operations that will ensure current and future test equipment orders are fulfilled and delivered with minimal delay.

Field specialist, Matt Campbell, sales team Doug Bigrigg, Jérémie Decressac and our agents around the world will continue to organize video conferences with you and provide solutions to advance your R&D projects.

At ViVitro Labs and ProtomedLabs, we are committed to protect the health and the safety of our employees and their families during this time.   We have been proactive in restricting business travel and client visits.  In compliance with local health authorities’ recommendations, our employees now work remotely from home whenever possible.

We will provide updates on our operations whenever necessary. On behalf of my team, I wish you and your family good health.

Karim Mouneimne
President
ViVitroLabs Inc. / ProtomedLabs SASU

Join over 5000 cardiovascular device professionals who receive our testing and engineering insights and tips every month.